Recro Pharma logo
Recro Pharma REPH
$ 1.4 -4.76%

Annual report 2023
added 03-22-2024

report update icon

Recro Pharma Financial Ratios 2011-2025 | REPH

Annual Financial Ratios Recro Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-10.0 -4.1 -5.4 -1.2 -19.9 -1.8 -3.0 -2.3 19.7 -1.1 - - -

P/S

1.4 0.9 0.8 0.5 3.7 1.9 2.1 1.0 1.1 - - - -

EPS

-0.1 -0.3 -0.3 -1.2 -0.8 -3.9 -2.6 -2.8 0.4 -2.8 -15.4 - -

EV (Enterprise Value)

220 M 164 M 155 M 127 M 469 M 281 M 246 M 116 M 138 M -1.17 M 1.01 M 15.7 M 13.6 M

EBITDA per Share

0.05 0.13 0.16 -0.1 1.26 -2.09 -1.3 -1.29 -0.165 -1.9 - - -

EV/EBITDA

13.4 -27.7 16.3 -4.0 -5.7 -2.1 -49.7 0.2 - - -

PEG

0.08 0.04 0.06 -0.01 -0.25 0.04 -0.44 0.0 0.17 0.0 - - -

P/B

2.3 1.4 1.5 -2.4 -55.3 -7.4 5.2 1.0 1.5 0.9 - - -

P/CF

-132.7 -22.2 5.7 - -11.0 -2.7 -6.3 -9.9 9.9 -1.6 - - -

ROE %

-22.63 -33.21 -27.03 195.04 277.56 408.84 -173.60 -42.18 7.52 -85.24 - - -

ROA %

-8.65 -12.63 -7.09 -26.59 -16.87 -51.27 -26.89 -16.51 2.19 -79.19 - - -

ROCE %

-6.09 0.47 0.98 59.16 24.76 -35.79 -20.15 -9.85 -2.54 -62.72 - - -

Current Ratio

1.6 1.6 1.4 0.9 9.3 2.5 1.7 5.2 4.1 14.1 - - -

DSO

62.7 56.4 50.7 64.3 85.5 85.3 49.2 54.8 60.5 - - - -

DIO

49.1 52.3 67.5 90.0 107.9 90.5 94.0 85.9 116.9 - - - -

DPO

6.6 9.7 12.8 9.4 7.1 38.1 76.0 40.6 20.2 - - - -

Operating Cycle

111.8 108.7 118.2 154.2 193.4 175.7 143.2 140.7 177.4 - - - -

Cash Conversion Cycle

105.2 99.0 105.4 144.8 186.3 137.6 67.2 100.1 157.2 - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
20232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011500 500 400 400 300 300 200 200 100 100 0 0 -100 -100 -200 -200
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Recro Pharma

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.05 -0.04 -0.06 - -0.06 -0.06 -0.08 - -0.07 0.03 -0.23 - -0.09 -0.25 -0.33 - -0.19 -0.13 -0.09 - -0.64 -0.62 -0.65 - -0.48 -0.46 -0.42 - -0.5 -0.83 -0.71 - -0.24 -0.17 -0.53 - -0.61 -0.36 -3.67 - -3.95 -4.97 -3.3 - - - - - - - -

EBITDA per Share

-0.02 -0.01 -0.01 - 0.01 0.01 0.02 - 0.1 0.12 -0.05 - 0.17 0.02 -0.05 - 0.52 0.55 0.27 - -0.56 -0.56 -0.57 - -0.46 -0.4 -0.29 - -0.19 -0.51 -0.34 - 0.14 0.21 -0.53 - -0.61 -0.36 - - 0.01 0.01 - - - - - - - - -

ROE %

-31.61 -33.18 -35.62 -28.69 -36.53 -34.92 -21.89 74.33 89.42 112.34 150.31 112.28 176.42 225.47 225.08 135.86 203.84 207.68 230.62 197.06 165.67 66.30 -29.59 -90.12 -97.63 -73.75 -54.07 -27.65 -32.99 -30.81 -23.05 -18.83 -43.73 -63.30 -74.81 -66.85 -64.04 -36.34 -17.89 8.76 8.76 5.96 2.28 - - - - - - - -

ROA %

-10.51 -9.68 -9.56 -7.04 -9.25 -9.26 -6.22 -8.75 -10.81 -10.66 -17.48 -15.31 -19.21 -21.05 -17.80 -8.26 -16.78 -21.41 -27.02 -24.71 -29.57 -25.91 -22.49 -13.96 -16.90 -14.98 -14.53 -10.82 -12.37 -10.99 -7.62 -5.48 -28.61 -50.19 -62.96 -62.11 -121.31 -157.38 -221.37 -184.94 -184.94 -125.73 -48.03 - - - - - - - -

ROCE %

-8.83 -5.20 -2.61 -0.75 0.00 0.15 6.31 40.55 22.94 4.58 4.82 7.83 -132.69 -255.62 -410.86 -344.96 -275.46 -65.42 151.06 203.84 166.73 60.13 -41.01 -95.10 -100.58 -68.95 -45.72 -21.95 -22.35 -17.28 -6.91 -9.74 -34.67 -59.19 -74.88 -39.70 -39.70 -14.77 - - - - - - - - - - - - -

Current Ratio

1.6 1.6 1.6 1.6 1.3 1.3 1.4 1.4 1.4 1.3 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.2 1.2 1.2 1.2 1.6 1.6 1.6 1.6 1.4 1.4 1.4 1.4 14.1 14.1 14.1 14.1 0.1 0.1 0.1 0.1 - - - - - - - -

DSO

58.6 64.4 66.1 - 71.1 60.4 56.0 - 66.4 63.9 58.3 - 42.7 53.1 49.1 - 52.0 42.0 49.6 - 64.2 54.0 52.6 - 51.6 52.2 48.9 - 56.0 55.0 48.8 - 47.3 42.0 - - - - - - - - - - - - - - - - -

DIO

57.7 64.3 51.8 - 50.5 46.6 52.1 - 60.0 61.1 64.4 - 90.2 91.1 66.7 - 124.7 97.5 81.7 - 115.2 80.9 89.3 - 130.5 85.9 80.8 - 138.9 83.6 78.8 - 81.6 87.2 - - - - - - - - - - - - - - - - -

DPO

13.9 16.6 9.1 - 15.3 10.2 10.3 - 10.7 10.0 10.6 - 14.0 14.2 7.0 - 8.2 6.4 10.0 - 48.6 34.1 54.2 - 105.5 69.5 52.5 - 65.6 39.5 25.2 - 14.1 15.1 - - - - - - - - - - - - - - - - -

Operating Cycle

116.3 128.7 117.8 - 121.6 107.0 108.1 - 126.5 125.0 122.7 - 133.0 144.2 115.8 - 176.7 139.6 131.3 - 179.4 134.9 142.0 - 182.1 138.1 129.7 - 195.0 138.6 127.6 - 129.0 129.2 - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

102.4 112.1 108.7 - 106.3 96.8 97.8 - 115.8 115.0 112.1 - 119.0 130.0 108.8 - 168.5 133.2 121.3 - 130.9 100.8 87.8 - 76.6 68.7 77.2 - 129.3 99.1 102.3 - 114.9 114.1 - - - - - - - - - - - - - - - - -

All numbers in USD currency